We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Oil,
I really, really hope that when this pandemic crisis is over, many ICUs are able for more comprehensive ARDS treatments when proved efficient. Yes, there is a risk that other efficient treatments will also be available. And this will not serve to our favor.
But, but. I think even in this case, Traumakine might be administered as a multi-organ failure treatment and product to market time and trials will not last for long years.
I really hope pandemic will make drug development faster and also more efficient.
Sax, Zum, all good points noted.
I do wonder though whether Faron's position is now enhanced due to the fact that subcutaneous Interferon Beta has been proven ineffective. Over the last 4/5 months all the articles ive been reading have pointed to the benefits of Interferon Beta. Do we hold the ACE card knowing that our IV product is patent protected? Does this strengthen our position now the BIG Pharma haven't been able to prove their products? Is a substantial partnering deal now more likely?
Unfortunately i don't know the answer to any of the above. However, as your points notes, by Christmas were likely to know.
Have a good weekend all.
£10-20k is released nearly every single day in Helsinki, by Lago's supporting hand. I wonder if some of the cash will not be seen in furter financing round(s). Even if it is so, I don't worry as SP is remaining quite stable despite the (missing) news. Well, bigger challenge is that current Covid19 cure developments will likely to deliver ARDS treatment as well as by-product. At least I have seen some reference about potential ARDS treatment by US drug developer. Time is running short and we have already seen how difficult is to administer Traumakine in the trials so far.
Faron confirm they have funding into Q1 2021. Anyone worried by that?
Thank you for the links Saxondale & Oilman. Informative weekend reading !
Faron are expecting the topline data from the first expansion cohorts for Clevegen Q4 2020 . Tie this in with the mentioned shareholder value period that Markku mentioned , and that is why we are thinking there may be some sort of announcement of potential partnering . Either way , if the results are looking good - it should add some value .
Regarding the steroids , so far the WHO have only shown results from injected Interferon . Our results have yet to come . But as many on here fear , it wouldn't surprise us for Farons patients to be a mix of steroid users . They don't appear to have a non steroid domain like they have in REMAP . Hence why the hurry on to get Hibiscus up and running maybe ( also penciled in for initiation in Q4 2020 ) . If the WHO make a bodge of our therapy by not following Farons recommendations , we will just have to shake it off and continue with REMAP & HIBISCUS . REMAP does seem pretty clued up on steroids , having done an extensive trial already . So the data they have been generating should help everyone understand how best our I/V drug will fit in , as they have be running it on patients with and without steroids .
Anyone getting a bit down in the dumps this week , could have a re-read of the latest presentation .
Plenty to look forward to .
https://www.faron.com/sites/default/files/H1-2020%20Faron%20presentation%20final.pdf
If Faron knew that" its interferon beta-1 formulation delivered intravenously, which the company reckons offers the best “delivery route” for critically ill patients." ( from Proactive) then why did WHO not follow those instructions... ? And the WHO pulled the plug on Remdesivir ( and others) but its now again become the flavour of the month..
Markku was certainly optimistic (again from Proactive in July) " "The scientific community is currently focused on discovering new therapeutics to treat coronavirus and we are very pleased to be supporting these efforts, now with three trials investigating the potential of Traumakine in severely ill patients. We continue to believe in the potential of Traumakine as a future treatment for ARDS" and one that could have significant impact on the intensive-care burden from COVID-19." Another statement is needed soon to reassure investors...
BTW can anyone confirm why they are expecting news on Clevegen soon ? The Ph2 trial is to complete in 2024 I believe ?
Time to start ignoring this forum for a bit probably, getting a bit personal.. hold for actual news
Mr 5k is back today! Lago starting to offload on the Naz!
This is nothing more than a tree shake! Below £3 then im buying more!!!!
Justice
I'm guessing your ugly wife dumped you and some hot Russian blonde has fallen in love with you
So lucky to have got out of this last week at 4.20 and to re-invest in NCYT at 7.70.....
As ever DYOR
Long you say what you like , I answered your question about being blind. Don't post drivel if you don't want an answer.
I invest with my money not urs. And I can say what I want same what u saying on this board. And when u wrong about something just admit and if this goes up I will put my hands up
Long i'm not blind , I can see whats happening , the SP is going down because WHO have said the drugs don't work, ( should be a song title) ...without even trying them out first.
If you cannot grasp what's going on by reading this board and the RNS's released , then I doubt the stock market is for you.
We're all in the same boat , suck it up or sell it is the easy way .
A further 1664 shares added
Step, go back and read a few ofvthe RNSs on clevegen over the past year and watch some of the interviews on YouTube for faron pharmaceuticals
Kindly enlighten us then please.
Ask those who were talking ten pound last few months very quite they r now. All intelligent persons r vanished
Some r still blind can’t see what is happening .
is now with the '2-6 month range'. Time will tell how significant!
On a separate note, it looks like we could be heading to last the placing price!!!